Global Nausea And Vomiting Treatment Market Growth (Status and Outlook) 2025-2031

Global Nausea And Vomiting Treatment Market Growth (Status and Outlook) 2025-2031

The global Nausea And Vomiting Treatment market size is predicted to grow from US$ 5759 million in 2025 to US$ 8519 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.

United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.

LPI (LP Information)' newest research report, the “Nausea And Vomiting Treatment Industry Forecast” looks at past sales and reviews total world Nausea And Vomiting Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Nausea And Vomiting Treatment sales for 2025 through 2031. With Nausea And Vomiting Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nausea And Vomiting Treatment industry.

This Insight Report provides a comprehensive analysis of the global Nausea And Vomiting Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nausea And Vomiting Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nausea And Vomiting Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nausea And Vomiting Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nausea And Vomiting Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Nausea And Vomiting Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Others

Segmentation by Application:
CINV
PONV
Motion Sickness
Pregnancy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Pharmanovia
Mylan
Duchesnay
GSK